DIAGNOS Provides Financing Updates
Momentum Public Relations
Press Release: June 29 2018
DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX VENTURE:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIREplatform based on Artificial Intelligence (AI), provides updates on financing activities previously announced on June 14, 2018.
Private placement of units
The Corporation announces a new closing date of July 4th, 2018 in connection with the private placement of units (each a “Unit”) for gross proceeds of up to $1,200,000. Each Unit consists of:
- One Secured, Convertible and Redeemable Debenture (“Debenture”), 3-year term, 10% annual interest, principal of $50,000 per Debenture, and
- 200,000 stock warrants (each a “Stock warrant”) entitling the holder to purchase one common share (“Share”) per Warrant at a price of $0.15 per Share, for a period of 18 months from the date of issuance of the Stock warrant.
Private placement – shares
The Corporation announces the cancellation of , 800,000 units (each a “Share-unit”), for gross proceeds of $60,000, in connection with the $120,000 private placement of common shares and stock warrants. Each Share-unit consists of;
- one common share (“Share”), and
- one stock warrant (“Warrant”) entitling the holder to purchase one Share per Warrant at a price of $0.10 per Share, for a period of 18 months from the date of issuance of the Warrant.
The cancellation is subject to receipt of all required regulatory approvals, including the approval of the TSX Venture Exchange, as well as the execution of formal documentation.
All monies quoted in this press release shall be stated and paid in lawful money of Canada.
About DIAGNOS
DIAGNOS is a publicly-traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence (“AI”) tool CARA (Computer Assisted Retina Analysis). CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (“POC”). CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients in real-time and has been cleared for commercialization by several regulatory authorities such as Health Canada, the U.S. Food and Drug Administration and the European Union.
Additional information about DIAGNOS is available at www.diagnos.com and www.sedar.com.
For further information, please contact:
Mr. André Larente, President | Mr. Josh Falle | ||
DIAGNOS Inc. | Momentum PR | ||
Tel: 450-678-8882 ext. 224 | Tel: 514-416-4656 | ||
alarente@diagnos.ca | josh@momentumpr.com |
This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Diagnos
Crystal Lake closes $700,000 1st tranche of financing
Crystal Lake Mining Corporation (the “Company” or “Crystal Lake”) is pleased to announce that it has closed the first tranche of a $1 million non-brokered private placement to strategic investors at 55 cents per unit for gross proceeds of $700,000. A total of 1,272,727 shares were issued to complete the first tranche. The second and final tranche of this “hard dollar” financing is expected to close next week.
Each unit of the $1 millionCrystal Lake private placement consists of one common share of the Company and one full share purchase warrant. Each warrant entitles the subscriber to purchase an additional common share at a price of 70 cents for 24 months. All securities will be subject to a statutory hold period of four months from closing.
Proceeds of the financing, which remains subject to regulatory approval, will be used to further advance the Company’s Nicobat Project in northwest Ontario and for general working capital purposes. A finder’s fee is payable to qualified recipients as permitted by the TSX-V.
About Crystal Lake Mining
Crystal Lake Mining is a Canadian-based junior exploration company focused on building shareholder value through the discovery of new magmatic nickel sulfide deposits using technical excellence in exploration target development.
Forward-Looking Information
This news release may contain certain “forward looking statements”. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Any forward-looking statement speaks only as of the date of this news release and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise.
On behalf of The Board of Directors of Crystal Lake Mining Corporation.
Alphonse Ruggiero, Director/CFO
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Crystal Lake Mining Corporation
View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/18/c3264.html
Contact:
MarketSmart Communications Inc., Tel: +1 (604) 261-4466, Toll free: 1-877- 261-4466, Email: info@marketsmart.ca; Momentum PR, Tel: +1 (514) 815-7473
- Published in Crystal Lake Mining, Uncategorized
Pacton Gold Closes $5.5 Million Private Placement
Momentum Public Relations
Press Release: May 9 2018
Pacton Gold Inc. (TSXV: PAC, OTC: PACXF) (the “Company” or “Pacton“) is pleased to announce that it has closed its previously announced brokered private placement for gross proceeds of $5,550,500 (the “Offering“). Sprott Capital Partners acted as lead agent, on behalf of a syndicate of agents including Red Cloud Klondike Strike Inc. (collectively, the “Agents“).
Under the Offering, the Company issued 24,132,609 units at $0.23 per unit, each unit consisting of one common share of the Company (a “Common Share“) and one transferable common share purchase warrant (a “Warrant“) (collectively, a “Unit“). Each Warrant will entitle the holder to acquire one Common Share for a period of three years from the date of issue at a price of $0.35.
In connection with the Offering, the Agents received a cash fee in an amount equal to 6.0% of the aggregate gross proceeds of the Offering and common share purchase warrants (the “Broker Warrants“) entitling the Agents to subscribe for that number of common shares equal to 6.0% of the aggregate number of Units placed in the Offering. Subject to regulatory approval, each Broker Warrant will be exercisable to acquire one Common share at a price equal to $0.35 for a period of three years after the closing date.
The net proceeds from the Offering will be used for exploration work to be conducted on the Company’s properties in Canada and Australia and for general working capital. All of the securities sold pursuant to the Offering will be subject to a four month hold period which will expire four months and one day from the date of issue in accordance with applicable securities laws. The Offering is subject to final acceptance of the TSX Venture Exchange.
Early Warning Dislcosure of Eric Sprott: Eric Sprott, through his holding company, 2176423 Ontario Ltd., acquired 8,695,700 Units under the Offering for total consideration of approximately $2 million. The 8,695,700 Units, represent approximately 10.1% of the outstanding Common Shares on a non-diluted basis and 18.4% on a partially diluted basis assuming the exercise of the Warrants. Prior to this purchase, Mr. Sprott did not directly or indirectly own any securities of the Company. The Units were acquired for investment purposes. Mr. Sprott has a long-term view of the investment and may acquire additional securities either on the open market or through private acquisitions or sell the securities either on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors. A copy of 2176423 Ontario Ltd.’s early warning report will appear with the Company’s documents on SEDAR at www.sedar.com and may also be obtained by contacting Mr. Sprott at (416) 362-7172 (200 Bay Street, Suite 2600, Royal Bank Plaza, South Tower, Toronto, Ontario M5J 2J1).
ON BEHALF OF THE BOARD OF DIRECTORS,
Alec Pismiris
Interim President & CEO
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act“) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
This news release includes certain forward-looking statements concerning the use of proceeds of the Offering, the future performance of our business, its operations and its financial performance and condition, as well as management’s objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including the speculative nature of mineral exploration and development, fluctuating commodity prices, competitive risks and the availability of financing, as described in more detail in our recent securities filings available at www.sedar.com. Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law.
SOURCE Pacton Gold Inc.
View original content: http://www.newswire.ca/en/releases/archive/May2018/09/c5600.html
Contact:
please contact 1-(855)-584-0258 or dom@pactongold.com.
- Published in Pacton Gold Inc.
ProSmart Closes $1,381.204.30 Non-Brokered Private Placement, Announces $1.75 Million Brokered Private Placement and Announces Issuance of Shares Under Services Agreement
Momentum Public Relations
Press Release:April 20 2018
ProSmart Enterprises Inc. (TSXV:PROS) (“ProSmart” or the “Company”), a global online network, connecting sports fans, teams and brands, is pleased to announce that it has closed the non-brokered private placement (the “Non-Brokered Offering”) announced on March 20, 2018 and is launching a brokered private placement (the “Brokered Offering”) led by Mackie Research Capital Corporation (“Mackie”).
Due to significant demand from investors associated with Mackie, ProSmart has decided to close on $1,381,205.49 of the proposed $2.1 million Non-Brokered Offering and has engaged Mackie to lead the Brokered Offering of up to $1.75 million. Both offerings (together, the “Offerings”) are for units with identical terms as described below. Mackie currently anticipates closing (the “Closing”) of the Brokered Offering shall take place on or about the week of April 30, 2018. Should the Brokered Offering close on the full $1.75 million, the Offerings would raise a combined total of $3,131,205, reflecting strong demand from investors.
The net proceeds from the Offerings will be used for general working capital purposes, funding of a fully integrated IR and marketing campaign and upgrading the technology platform through the software development agreement with Firestitch Inc. (“Firestitch”) announced on March 8, 2018.
Says Alan Schuler, CEO and Co-founder of ProSmart, “We are thrilled to see such strong demand for the Offerings and are especially pleased with the additional support that Mackie has offered to provide the Company. Mackie is one of Canada’s largest independent brokerage firms, with a full team of financial advisors and investment bankers, as well as institutional sales, trading and research professionals. This relationship will be very beneficial for us as we look to grow from a small cap company into something much larger.”
Description of Units
The units (the “Units”) for the Offerings are priced at $0.35 per Unit. Each Unit consists of one common share in the capital of the Company (a “Share”) and one transferable common share purchase warrant (a “Warrant”), with each Warrant exercisable into one additional Share at a price of $0.45 for a period of two years from closing.
The Company has the option to force conversion through an acceleration clause (the “Acceleration Clause”). The Acceleration Clause gives the company the right beginning on the date that is four months plus one day following closing, in the event that the weighted average daily trading price of the Shares on the TSX Venture Exchange (the “TSXV”) is $0.55 or more per Share for 10 consecutive trading days, in which case the Company may accelerate the expiry date of the Warrants by giving notice to the holders thereof (by disseminating a press release advising of the acceleration of the expiry date of the Warrants) and, in such case, the Warrants will expire on the thirtieth day after the date of such notice.
Non-Brokered Offering
ProSmart closed the sale of 3,946,298 Units for gross proceeds of $1,381,204.30 on April 20, 2018. All securities issued in connection with the closing of the Non-Brokered Offering are subject to a statutory hold period of four months plus one day in accordance with applicable securities legislation expiring on August 21, 2018. The Warrants issued in connection with the Non-Brokered Offering expire on April 20, 2020 and the Acceleration Clause for these warrants can be exercised on or after August 21, 2018.
In connection with the closing of the Non-Brokered Offering, ProSmart paid finder’s fees totaling $5,045.01 in cash and issued 14,414 non-transferable finders warrants (the “Finders Warrants”). Each Finders Warrant is exercisable into one Share at a price of $0.45 for a period of two years, expiring on April 20, 2020. The Finders Warrants are also subject to the Acceleration Clause.
The Non-Brokered Offering is subject to the final acceptance of the TSXV.
Brokered Offering
Mackie is acting as lead agent and sole bookrunner, on a best-efforts basis, for the Brokered Offering of up to 5,000,000 of Units resulting in gross proceeds of up to $1,750,000. The Company has granted Mackie an option (the “Agent’s Option”) exercisable at any time up to and including Closing to increase the size of the Brokered Offering by up to 15% in Units by giving written notice of the exercise of the Agent’s Option, or a part thereof.
The Brokered Offering will take place by way of a private placement to qualified investors in the provinces of Alberta, British Columbia, and Ontario, and otherwise in those jurisdictions where the Brokered Offering can lawfully be made, including the U.S., under applicable private placement exemptions. The Brokered Offering is subject to the acceptance of the TSXV and all securities issued thereunder will be subject to a statutory hold period of four months plus one day under applicable securities legislation.
At Closing, the Company will pay to Mackie a cash commission of 8% of the aggregate gross proceeds arising from the Brokered Offering (the “Commission”), such Commission also being applicable on gross proceeds arising from the exercise of the Agent’s Option, where any such exercise occurs. At Closing, and subject to regulatory approval (where any such approval is required), Mackie will receive options (the “Compensation Options”) exercisable at any time up to two years following Closing to purchase broker units (the “Broker Units”) of the Company in an amount equal to 8% of the number of Units sold in connection with the Brokered Offering, including the amount subscribed for pursuant to the exercise of the Agent’s Option, where any such exercise occurs. The Compensation Options shall be exercisable at the price of $0.35 per Broker Unit. Each Broker Unit is comprised of one Share and one non-transferable broker warrant (the “Broker Warrant”). Each Broker Warrant is exercisable into an additional Share at $0.45 for two years from the Closing subject to the Acceleration Clause. The Company shall also pay to Mackie a non-refundable work fee of $35,000 and a payment for advisory services to be satisfied upon the issuance of 100,000 Shares of the Company at the transaction price of $0.35 per Share. The certificate representing such Shares will include a legend indicating that such Shares are subject to a statutory hold period of four months plus one day.
The Brokered Offering is subject to certain conditions, including, but not limited to, completion of satisfactory due diligence and receipt of all necessary regulatory approvals, including the acceptance of the TSXV.
Shares for Services
The Company announces that it has issued 84,885 Shares to Firestitch in payment of an invoice issued under the software development agreement previously announced on March 8, 2018 and approved by the TSXV on March 26, 2018. The invoice owing to Firestitch is in the amount of $54,156.75. The number of Shares to be issued is based on a deemed price of $0.638 per Share, calculated as the average price per Share on the TSXV for the five days subsequent to the end of the month in which the services were performed.
Alan Schuler
Co-Founder & Chief Executive Officer
About ProSmart Enterprises Inc.
ProSmart (TSX-V:PROS) is a global online network connecting sports fans, teams and brands and is an emerging leader in sports content marketing through online tools and mobile apps. ProSmart works with over 1,500 governing bodies in more than 100 countries and provides unprecedented access to the $1.3 trillion sports market through its proprietary marketplace engine. ProSmart is also the first-and-only company to provide educational content created exclusively by hall-of-fame and professional athletes, which has been a key driver in building the company’s online network and connecting with youth, amateur and professional sports fans and players. ProSmart is a publicly traded company listed on the TSX-V.
For more information on ProSmart and its platforms, please visit the following links:
ProSmart Inc.: http://prosmartinc.com
RosterBot Inc.: http://rosterbot.com
ProSmart Hockey: http://prosmarthockey.com
ProSmart Football (Soccer): http://prosmartfootball.com
Stay connected with ProSmart by following us on:
LinkedIn (www.linkedin.com/company/prosmartsports)
CrunchBase (www.crunchbase.com/organization/prosmart-sports-development-inc)
AngelList (www.angel.co/prosmart-sports-development)
For further information please contact:
Ty Summach, Chief Operating Officer
t: 1-844-927-6278 ext. 103
e: investment@prosmartsports.com
The shares of ProSmart Enterprises Inc. trade publicly on the TSX Venture Exchange under the symbol TSXV:PROS.
“Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities issued, or to be issued, under the Offering have not been, and will not be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
To view the original release, please click here
Source: ProSmart Enterprises Inc. (TSX Venture:PROS, FWB:1R6)
To follow ProSmart Enterprises Inc. on your favorite social media platform or financial websites, please click on the icons below.
- Published in Prosmart Enterprises
Tetra Bio-Pharma Inc. Announces the Closing of $4,292,000 Non-Brokered Private Placement
Momentum Public Relations
Press Release: March 28 2018
Tetra Bio-Pharma Inc.(TBP:V), a global leader in cannabinoid-based drug development and discovery, is pleased to announce it has closed its non-brokered private placement of 4,292,000 units at a price of $1.00 per unit for aggregate gross proceeds of $4,292,000. Each unit consists of one common share and one non-transferable warrant, with a whole warrant entitling the holder to purchase one common share at a price of $1.30 per share for a period of thirty-six months expiring March 28th, 2021.
The Corporation intends to use the net proceeds of the Offering to advance its Phase 3 trial for PPP001 and other clinical trials, to effect the repayment of indebtedness, for the support of its commercial efforts and for general corporate and working capital purposes.
The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date. Completion of the private placement remains subject to the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange.
The securities described herein have not been, and will not be, registered under the U.S. Securities Act or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
The Corporation paid commissions in association with the financing of an aggregate of $275,800 in cash and the issuance of 275,800 finders’ warrants to GMP Richardson and IA Securities, exercisable at a price of $1.00 for a period of 24 months from closing. Each finders’ warrant is exercisable into a common share and common share purchase warrant, which is exercisable at a price of $1.30 per common share purchase warrant for a period of 24 months from the closing of the financing.
The TSX Venture Exchange Inc. has not approved the contents of this press release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.
More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
- Published in Tetra Bio Pharma
Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement
Momentum Public Relations
Press Release: March 16 2018
Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that it is conducting a non-brokered private placement of up to 4,500,000 units at a price of $1.00 per unit for aggregate gross proceeds of up to $4,500,000.
Each unit will consist of one common share (a “Common Share”) in the Company and one warrant (a “Warrant” and collectively the “Warrants”). Each Warrant will entitle the holder thereof to acquire one Common Share at a price of $1.30, for a period of 36 months from the closing date.
The private placement is expected to close on or about March 31st, 2018.
The securities issued pursuant to the private placement will be subject to a four-month hold period from the closing date. Completion of the private placement remains subject to the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange.
The Company intends to use the net proceeds of the Offering to advance the Company’s Phase 3 trial for PPP001 and other clinical trials, to effect the repayment of indebtedness, for the support of its commercial efforts and for general corporate and working capital purposes.
The TSX Venture Exchange Inc. has not approved the contents of this press release. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities described herein have not been, and will not be, registered under the U.S. Securities Act or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.
More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Corporation believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Corporation’s ability to control or predict, that may cause the actual results of the Corporation to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the failure to obtain sufficient financing to execute the Corporation’s business plan; the success of the Rx Princeps™product offering and inhalation device; guidance on expected sales volumes associated with the Rx Princeps™product offering and inhalation device; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Corporation’s public disclosure record on file with the relevant securities regulatory authorities. Although the Corporation has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tetra Bio-Pharma Inc.
Dr. Anne-Sophie Courtois, DVM
Vice President, Marketing & Communications
(438) 899-7575
For investors information, please contact:
investors@tetrabiopharma.com
(438) 504-5784
- Published in Tetra Bio Pharma
Klondike Silver Closes Private Placement
Momentum Public Relations
Press Release: January 24, 2018
Klondike Silver Corp. (the “Company”) (TSX.V: KS): The Company announces that it is closing the second and final tranche of the non-brokered private placement (the “Private Placement”) announced November 29, 2017. The second tranche represents 10,000,000 units raising gross proceeds of $500,000. The first tranche closed December 1, 2017 and also represented 10,000,000 units raising gross proceeds of $500,000. All shares are subject to a four month hold period which will expire on April 2, 2018 for tranche one and May 25, 2018 for tranche two. In connection with the placement, the Company paid a finder’s fee of $82,700 to qualified finders. Completion of the Private Placement is subject to the approval of the TSX Venture Exchange. The net proceeds will be used for advancing Klondike’s Silver Lead Zinc project and for general working capital.
About Klondike Silver
Klondike Silver’s Royalty Free SILVER LEAD ZINC land package (100 km2) is located in the SLOCAN MINING CAMP (Southeast British Columbia – 138 km North of Teck’s Silver Lead Zinc smelter (Trail B.C.)). Based on the British Columbia MINFILE mineral database, sixty eight (68) of the one hundred and seventy three (173) past producing Silver Lead Zinc mines in the Slocan Mining Camp are located in the Klondike Silver land package. Klondike Silver has created the first real opportunity to invest in and properly explore a sizeable portion of one of the most historic mining camps in British Columbia. Klondike likes to think of the Slocan as the last best under explored Silver Lead Zinc camp in Canada. For additional information please visit the company website www.klondikesilver.com.
CONTACT INFORMATION
Corporate Inquiries:
Dale Dobson: (604) 682-2928
Email: dale.dobson@klondikesilver.com
On Behalf of the Board of Directors
Klondike Silver Corp.
“Thomas Kennedy”
Thomas Kennedy, B.Comm., J.D.
CEO, Director
This news release contains certain forward looking statements which involve known and unknown risks, delays, and uncertainties not under the control of Klondike Silver Corp. which may cause actual results, performance or achievements of Klondike Silver Corp. to be materially different from the results, performance or expectation implied by these forward looking statements. By their nature, forward looking statements involve risk and uncertainties because they relate to events and depend on factors that will or may occur in the future. Actual results may vary depending upon exploration activities, industry production, commodity demand and pricing, currency exchange rates, and, but not limited to, general economic factors.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Klondike Silver Corp.
Albert Mining Inc. Announces the Closing of the 2nd Tranche of its Non-Brokered Private Placement
Momentum Public Relations
Press Release: January 19, 2018
Albert Mining Inc. (“Albert” or “Corporation”) (TSX-V: AIIM) , an exploration mining company and a leader in the use of artificial intelligence and advanced knowledge-extraction techniques in the mining sector, is pleased to announce the closing of the second tranche of its non-brokered private placement of 10 million units at $0.05 per unit comprised of one common share and one common share purchase warrant (the “Warrant”). Each Warrant entitles the holder thereof to acquire one additional common share in the capital of the Corporation at a price of $0.07 per common share for a period of twenty-four (24) months following the closing of the Offering for gross proceeds of $500 ,000.
In connection with the 2nd tranche of the private placement, the Corporation is paying a finder’s fee of $2,100 and issuing 42,000 finder’s warrants. Each finder’s warrant entitles the holder to purchase one additional common share in the capital of the Corporation at a price of $0.065 per common share for a period of twenty-four (24) months expiring January 19, 2020.
An insider of the Corporation has participated in the 2 nd tranche of the private placement by purchasing 2.4 million units.
All securities issued in the private placement are subject to a four-month hold period and to all necessary regulatory approvals, including the approval of the Exchange.
The proceeds of the financing will be used for exploration and working capital.
About Albert Mining Inc.
Albert is a junior mining exploration company with an extensive portfolio of gold and diamond properties in Quebec. Albert also recently acquired assets from DIAGNOS Inc.’s mining division, including the Computer Aided Resources Detection System (“CARDS”). Albert can count on a multidisciplinary team that includes professionals in geophysics, geology, Artificial Intelligence, and mathematics. The Company’s objective is to develop a new royalty stream by significantly enhancing and participating in the exploration success rate of mining.
For further information, please contact:
Michel Fontaine
President and CEO of Albert Mining Inc.
Telephone: 514-994-5843
Fax: 613-422-0773
Email: michel@albertmining.com
Website: www.albertmining.com
Additional information about the Company is available under Albert’s profile on SEDAR at www.sedar.com .
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
- Published in Albert Mining, Artificial Intelligence, Mining
Crystal Lake Closes Private Placements
Momentum Public Relations Press Release: January 17, 2018
Crystal Lake Mining Corporation (the "Company") is pleased to announce that it has closed the $500,000 f --->low-through private placement announced on October 26, 2017 and referenced in a press release on November 27, 2017 and t --->he $400,000 non-flow-through private placement announced on October 25, 2017, and referenced in press releases dated Nov --->ember 6, 2017 and November 27, 2017. The Company has issued 2,000,000 flow-through units ("FT Units") for gross proceeds of $500,000. Each FT Unit consists o --->f one common issued at $0.25 per share and one-half common share purchase warrant (each whole share purchase warrant bei --->ng a "Warrant"). Each Warrant may be exercised by the holder to purchase an additional common share at a price of $0.30 --->For 18 months from closing. The Company has also issued 2,000,000 non-flow-through units ("NFT Units") for gross proceeds of $400,000. Each NFT Unit ---> consists of one common share issued at $0.20 per share and one common share purchase warrant (a "Warrant"). Each Warran --->t may be exercised by the holder to purchase an additional common share at a price of $0.25 For 18 months from closing. The proceeds from the private placements will be used to advance exploration activities at the Company's Canadian proper --->ties and for general working capital. Finder's fees of $4,200 and 21,000 Warrants were paid in connection with the NFT Unit issuances and $14,752.50 and 59,01 --->0 Warrants were paid in connection with the FT Unit issuances. The NFT Units have a four-month hold period expiring on April 4, 2018 and the FT Units have a four-month hold period exp --->iring on April 12, 2018. About the Company Crystal Lake Mining Corporation is a mineral exploration/Development company focused on creating value through the explo --->ration and development of its British Columbia and Ontario mineral properties. On behalf of The Board of Directors of Crystal Lake Mining Corporation. Alphonse Ruggiero, Director/CFO This news release contains certain forward looking statements which involve known and unknown risks, delays, and uncerta --->inties not under the control of Crystal Lake Mining Corporation which may cause actual results, performance or achieveme --->nts of Crystal Lake Mining Corporation on to be materially different from the results, performance or expectation implie --->d by these forward looking statements. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Ve --->nture Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by ma --->nagement.
- Published in Crystal Lake Mining, Mining
ATW Tech Completes a Private Placement of Units of $423,640
Momentum Public Relations
Press Release: December 22, 2017
AtmanCo inc. (“AtmanCo” or the “Company”) (TSX-V:ATW) is pleased to announce the closing of a private placement consisting of the issuance of 3 530 333 units at a price of $0.12 per unit, for total gross proceeds of $423,640. Each unit consists of one common share and one common share purchase warrant giving the holder the right to subscribe for one common share at a price of $0.15 from a period of 3 years.
The securities issued under this private placement are subject to a four-month hold period. This private placement remains subject to the approval of the TSX Venture Exchange. A commission of $840 is paid to a broker.
Additional information regarding the Company is available on SEDAR www.sedar.com. The TSX Venture Exchange and its Regulatory Services provider (as per meaning assigned to this term in TSX Venture Exchange’s policies) bear no liability as to the relevance or accuracy of this press release.
ABOUT ATW TECH
ATW Tech (‘AtmanCo’) (TSX-V:ATW) is a leader in information technology, owner of several web platforms including VoxTel, Québec Rencontres, VuduMobile, Atman and Bloomed. VoxTel offers various interactive landline and mobile carrier billing phone solutions. Quebec Rencontres is a web and mobile social network application catered to building serious and sustainable relationships. VuduMobile is specialized the text messaging business for enterprises through its unique, user-friendly and bilingual test messaging application et turnkey solution allowing management of text message management programs in all kind of businesses. Atman and its APIs enable companies to optimize their human capital. Bloomed is a cloud-based platform to manage data (smart data) on consumers and their behaviors, which is developed for marketing agencies and their campaigns for the consumer and corporate markets.
SOURCE:
ATW TECH (AtmanCo) | ||
Michel Guay | Simon Bédard, CA, CPA, CFA, MBA | |
Founder, president and CEO | CFO | |
Tel.: 514.935.5959 ext. 301 | Tel. : 514.935.5959 ext. 304 | |
mguay@atmanco.com | sbedard@atmanco.com | |
www.atwtech.com |
- Published in Atmanco